Interventional trials might explore whether maintaining Hb above a certain threshold in hypertensive-ICH patients (through transfusion or other means) can reduce AKI incidence—essentially translating our mediation finding into a testable hypothesis. This evidence concerns the gene GSTM1 and acute kidney injury.